Olympiad Research’s Cardinal Health CAH Stock Holding History

Olympiad Research’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-7,752	Closed	-$405K	–	359
2020 Q2	$405K	Buy	+7,752	New	+$400K	0.29%	56

Other funds holding CAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Olympiad Research's CAH Position: Q3 2020 in Review

Olympiad Research sold out of Cardinal Health (CAH) in Q3 2020, closing a stake of 7,752 shares — an estimated $405K sold.

Olympiad Research first reported a position in CAH in Q2 2020 and held it in 1 quarter. The position peaked at $405K in Q2 2020. 741 funds tracked by Wall St. Rank hold CAH as of Q3 2020.

Olympiad Research reported no remaining Cardinal Health position as of Q3 2020 after selling out during the quarter.
Olympiad Research sold 7,752 Cardinal Health shares in Q3 2020, an estimated $405K.
Olympiad Research first reported a position in Cardinal Health in Q2 2020 and held it in 1 quarter.
Olympiad Research's Cardinal Health position peaked at $405K in Q2 2020.
741 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2020.

Based on Olympiad Research's 13F filing for Q3 2020, filed 2 Nov 2020.